Sabrina Martucci Johnson | President and CEO |
Lisa Walters-Hoffert | CFO |
John Fair | Chief Business Officer |
Yasmeen Rahimi | ROTH Capital Partners |
Caroline Palomeque | Maxim Group |
Brian Marckx | Zacks Investments Research |
Welcome to the conference call hosted by Daré Bioscience to provide Financial Results for the Quarter Ended December 31, 2018, and a General Business Update. This call is being recorded. My name is Chris, and I’ll be your operator today. With us today are Sabrina Martucci Johnson, Daré’s Chief Executive Officer; Lisa Walters-Hoffert, Daré’s Chief Financial Officer; and John Fair, Daré’s Chief Business Officer. Miss Johnson, please proceed.